Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides · page 22 of 28
The slide outlines a sequential cohort design for a clinical trial, moving from IV to SC administration.
Pitch deck · roadmap · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 list 1/1 paragraph 1/1 title 2/2
Components 5
timeline bullet paragraph action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1